Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 4
1982 2
1983 2
1984 2
1985 5
1986 4
1987 3
1988 1
1989 2
1990 2
1994 1
1995 2
1996 2
1998 2
1999 5
2000 3
2001 4
2002 8
2003 9
2004 9
2005 6
2006 12
2007 17
2008 11
2009 16
2010 13
2011 13
2012 22
2013 39
2014 42
2015 62
2016 68
2017 67
2018 80
2019 103
2020 122
2021 105
2022 142
2023 137
2024 63

Text availability

Article attribute

Article type

Publication date

Search Results

1,100 results

Results by year

Filters applied: . Clear all
Page 1
Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial.
Ray KK, Troquay RPT, Visseren FLJ, Leiter LA, Scott Wright R, Vikarunnessa S, Talloczy Z, Zang X, Maheux P, Lesogor A, Landmesser U. Ray KK, et al. Among authors: zang x. Lancet Diabetes Endocrinol. 2023 Feb;11(2):109-119. doi: 10.1016/S2213-8587(22)00353-9. Epub 2023 Jan 5. Lancet Diabetes Endocrinol. 2023. PMID: 36620965 Free article. Clinical Trial.
Sorting nexin 5 mediates virus-induced autophagy and immunity.
Dong X, Yang Y, Zou Z, Zhao Y, Ci B, Zhong L, Bhave M, Wang L, Kuo YC, Zang X, Zhong R, Aguilera ER, Richardson RB, Simonetti B, Schoggins JW, Pfeiffer JK, Yu L, Zhang X, Xie Y, Schmid SL, Xiao G, Gleeson PA, Ktistakis NT, Cullen PJ, Xavier RJ, Levine B. Dong X, et al. Among authors: zang x. Nature. 2021 Jan;589(7842):456-461. doi: 10.1038/s41586-020-03056-z. Epub 2020 Dec 16. Nature. 2021. PMID: 33328639 Free PMC article.
Reply.
Nosyk B, Zang X, Krebs E. Nosyk B, et al. Among authors: zang x. J Acquir Immune Defic Syndr. 2022 Oct 1;91(2):e4-e5. doi: 10.1097/QAI.0000000000003034. J Acquir Immune Defic Syndr. 2022. PMID: 36094491 Free PMC article. No abstract available.
KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
Wei Y, Ren X, Galbo PM Jr, Moerdler S, Wang H, Sica RA, Etemad-Gilbertson B, Shi L, Zhu L, Tang X, Lin Q, Peng M, Guan F, Zheng D, Chinai JM, Zang X. Wei Y, et al. Among authors: zang x. Sci Immunol. 2021 Jul 9;6(61):eabf9792. doi: 10.1126/sciimmunol.abf9792. Sci Immunol. 2021. PMID: 34244312 Free PMC article.
Erratum.
Liu K, Wu X, Zang X, Huang Z, Lin Z, Tan W, Wu X, Hu W, Li B, Zhang L. Liu K, et al. Among authors: zang x. Oncol Res. 2020 Dec 10;28(5):559-560. doi: 10.3727/096504020X16032056440102. Oncol Res. 2020. PMID: 33349309 Free PMC article.
1,100 results